Simulations Plus (NASDAQ:SLP) Updates FY 2026 Earnings Guidance

Simulations Plus (NASDAQ:SLP) updated its FY 2026 earnings guidance on Friday. The company provided EPS guidance of 0.750-0.850 for the period, compared to the consensus estimate of 0.860. The company issued revenue guidance of $79.0 million-$82.0 million, compared to the consensus revenue estimate of $81.6 million.

Analysts Set New Price Targets

Several brokerages recently commented on SLP. Wall Street Zen lowered shares of Simulations Plus from a “buy” rating to a “hold” rating in a report on Saturday, June 13th. Weiss Ratings upgraded Simulations Plus from a “sell (d-)” rating to a “sell (d)” rating in a research report on Friday, June 5th. TD Cowen lowered their price target on shares of Simulations Plus from $19.00 to $16.00 and set a “hold” rating on the stock in a research report on Friday, April 10th. Craig Hallum cut Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 target price for the company. in a report on Thursday, June 18th. Finally, William Blair lowered Simulations Plus from an “outperform” rating to a “market perform” rating in a research report on Wednesday, June 17th. One investment analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Simulations Plus presently has a consensus rating of “Hold” and a consensus price target of $19.88.

Simulations Plus Trading Up 0.4%

Simulations Plus stock opened at $18.34 on Friday. The stock has a market cap of $370.47 million, a PE ratio of -5.86 and a beta of 1.30. The stock has a 50-day moving average price of $16.47 and a 200 day moving average price of $15.47. Simulations Plus has a 52 week low of $11.09 and a 52 week high of $21.01.

Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings results on Thursday, July 9th. The technology company reported $0.30 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.07. Simulations Plus had a negative net margin of 77.96% and a positive return on equity of 16.21%. The business had revenue of $21.89 million during the quarter, compared to the consensus estimate of $20.90 million. On average, equities analysts predict that Simulations Plus will post 0.8 EPS for the current year.

Insider Transactions at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 4,177 shares of the company’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $18.44, for a total transaction of $77,023.88. Following the completion of the sale, the director directly owned 3,202,131 shares in the company, valued at $59,047,295.64. This represents a 0.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 6,177 shares of company stock worth $108,754 over the last ninety days. 19.10% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Simulations Plus

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Invesco Ltd. lifted its holdings in Simulations Plus by 34.7% in the 4th quarter. Invesco Ltd. now owns 26,641 shares of the technology company’s stock worth $486,000 after buying an additional 6,863 shares in the last quarter. Corient Private Wealth LLC bought a new position in shares of Simulations Plus in the fourth quarter worth $397,000. Susquehanna Portfolio Strategies LLC lifted its stake in shares of Simulations Plus by 43.7% in the 4th quarter. Susquehanna Portfolio Strategies LLC now owns 67,002 shares of the technology company’s stock worth $1,221,000 after acquiring an additional 20,389 shares during the period. Janus Henderson Group PLC bought a new position in shares of Simulations Plus in the fourth quarter valued at approximately $973,000. Finally, Balyasny Asset Management L.P. acquired a new position in shares of Simulations Plus during the 4th quarter valued at $683,000. 78.08% of the stock is owned by institutional investors and hedge funds.

Simulations Plus Company Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.